Jump to content

Search the hub

Showing results for tags 'Screening'.


More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Digital health and care service provision
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
    • Questions around Government governance
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Safety stories
    • Stories from the front line
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Patient Safety Commissioner
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient Safety Partners
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning campaigns
    • Patient Safety Learning documents
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training & education
  • Research, data and insight
    • Data and insight
    • Research
  • Miscellaneous

News

  • News

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End


Group


First name


Last name


Country


Join a private group (if appropriate)


About me


Organisation


Role

Found 165 results
  1. Content Article
    This guide by The Eve Appeal and The Survivors Trust outlines some simple actions healthcare professionals can take to make cervical screening appointments easier for patients and service-users who are survivors of rape or sexual abuse. It is part of the #CheckWithMeFirst campaign to help raise awareness of the challenges survivors of rape, sexual abuse and sexual violence may face when accessing cervical screening. They have also produced a cervical screening guide for survivors of rape, sexual abuse or assault, which can be found on the hub here.
  2. Content Article
    This guide by The Eve Appeal and The Survivors Trust gives information about attending cervical screening for survivors of rape, sexual abuse or assault. It offers tips that may help patients feel more comfortable about their appointment. It is part of the #CheckWithMeFirst campaign to help raise awareness of the challenges survivors of rape, sexual abuse and sexual violence may face when accessing cervical screening.
  3. Community Post
    Lets talks NEWS... Nurse and carer worry, I like to think that Critical Care outreach teams take this very seriously and that the 'worry' has a heavy influence in our management. Many of our patients may score 0, but warrant a trip to the ITU (AKI patients for instance). However, as part of our escalation policy it states that staff should alert the doctor and or the Outreach team when NEWS is 5 or 3 in one parameter. This causes the 'radar referral effect'. We often have a group of these patients on our list. Personally, I find them difficult to prioritise as they are often receiving frequent observations and have a plan. By concentrating on this group and make sure they have everything in place can take time, but... what about those not scoring in this threshold? Do they get pushed to the bottom of the list? Should nurses follow this protocol to safeguard themselves as well as the patient or are we not looking for sick patients in the right place? Don't get me wrong, the NEWS has been revolutionary in the way we deal with deterioration, but as a tool to prioritise this may not be the case. There are softer signs at play here....has anyone got any solutions to deal with the 'radar referals' Lots to discuss @Ron Daniels @Emma Richardson @LIz Staveacre @Danielle Haupt @Kirsty Wood
  4. Content Article
    In December 2022, Public Policy Projects brought together oncology experts and key stakeholders for a roundtable to discuss how effective partnership working in healthcare environments can reduce health inequalities in breast cancer outcomes. The objective of the roundtable was to create a series of actionable insights and recommendations for health providers to create a more resilient health and care system and, ultimately, improve breast cancer outcomes in the UK. This document is a summary of the key outcomes, insights and recommendations that were generated from the roundtable. It is not an exhaustive report of facilitating and enabling partnerships to tackle health inequalities, but rather a particular view from a group of key sector stakeholders.
  5. Content Article
    The U.S. Preventive Services Task Force (USPSTF) recently changed its recommendations for all women to get screened for breast cancer every other year starting at age 40 instead of 50. Wanda Nicholson, USPSTF Vice Chair and professor at George Washington University said the updated recommendations “will save more lives among all women.” However, time and time again, the evidence shows that screening healthy women using mammograms in fact, does not save lives. Dr Maryanne Demasi discusses the evidence.
  6. Content Article
    In this interview, we speak to sociologist Dr Marieke Bigg about why she decided to write her debut non-fiction This won’t hurt: How medicine fails women. Marieke discusses how societal ideas about the female body have restricted the healthcare system’s approach to women’s health and describes the impact this has had on health outcomes. She also highlights areas where the health system is reframing its approach by listening to the needs of women and describes how simple changes, such as allowing women to carry out their own cervical screening at home, can make a big difference.
  7. News Article
    Two years of the pandemic have meant drops in essential screening and detection in Australia, while cancer patients undergo treatments alone and isolate to avoid Covid risks. When Claire Simpson turned 50 in early 2020, she received a letter telling her to get a mammogram. Then the pandemic hit, and Victoria went into lockdown. “Like many people, I put it off until we were coming out of that lockdown, but by then it was September and I couldn’t get an appointment until December,” she says. In February 2021 she was diagnosed with breast cancer and had a mastectomy. Tests showed she was positive for the aggressive HER2 receptor, so she began 12 weeks of chemotherapy as well as a treatment called Herceptin, which she received an IV infusion of every three weeks. Simpson says the delay in screening “really, really delayed diagnosis for me, by a good six months”. “I can’t help but feel that [an earlier screening] could have probably saved me from having to have chemotherapy and this Herceptin infusion therapy that I’m having,” she says. Her last Herceptin treatment was last Wednesday. She has been living in self-imposed lockdown, terrified as the Omicron wave built that she would have to isolate due to Covid and disrupt her treatment. That self-imposed isolation will continue until her final surgery, an elective operation scheduled for mid-year. Cancer screening dropped by 10% in Victoria alone in the first year of the pandemic. In 2021, referrals to the Peter MacCallum Cancer Centre, a leading treatment and research facility in Melbourne, were down 40%. “That is certainly going to bounce back at some point,” says Prof Sherene Loi, an oncologist and researcher at Peter MacCallum. “It is potentially going to be a real problem in a few years’ time. At the moment we have a lot of very young cancer diagnoses, a lot of breast cancer … we are just flat chat.” Read full Source: The Guardian, 13 February 2022
  8. News Article
    Changes in cervical cancer screenings will help save lives, not put them at risk, according to a top gynaecologist. Prof Alison Fiander said people should not be worried screenings have dropped from every three to every five years in Wales as tests are "more effective". Public Health Wales (PHW) said the new rules were for people aged 25 to 49. More than 1.2 million people backed calls for a rethink in a UK petition and politicians in Wales will debate it after 30,000 signed a Senedd petition. Women and people with a cervix - as it could also affect trans men too - who had not tested positive for human papillomavirus (HPV) will now wait two more years between tests. Health chiefs in Wales said they changed the interval between screenings to the same time as those in Scotland because tests are now more accurate. Cervical screening gaps in England and Northern Ireland remain at three years. But Wales' public health body did publicly apologise for causing "concern", and admitted health chiefs "hadn't done enough to explain the changes". Prof Fiander, a clinical lead at the Royal College of Obstetricians and Gynaecologists, said PHW had "missed an opportunity" to help educate people but reassured the public the change was safe and not a cost-cutting exercise. Read full story Source: BBC News, 18 January 2022
  9. News Article
    An urgent debate has been called in the Senedd over a move to extend routine cervical screenings in Wales from every three years to five years. Public Health Wales (PHW) said those aged 25-49 who had not tested positive for human papillomavirus (HPV) would now wait two more years between tests. PHW said it was because the screening tests are now more accurate. However, 30,000 people signed a petition against it, citing the risk it could cause an increase in deaths. Particularly concerned are those who have not received the HPV vaccine, a national immunisation programme for which began in 2008 for girls aged 12 to 13. The number of signatures on the official petition on the Welsh Parliament's website was more than enough to trigger the issue to be looked at. The change follows a recommendation from the UK National Screening Committee. Last week, Public Health Wales apologised for causing "concern" over how it explained changes to screenings following its announcement. Read full story Source: BBC News, 10 January 2022
  10. News Article
    Screening for prostate cancer could be possible in the next five years, according to one of the UK's leading experts. Prof Ros Eeles, from the Institute of Cancer Research, said advances in genetics and medical imaging were making it possible. About 50,000 people in the UK are diagnosed with the disease each year, and nearly 12,000 die. NHS England said prostate screening had been notoriously tricky. Despite it being one of the most common cancers, there is no equivalent of the regular mammograms that detect breast cancer. There is a blood test that looks for levels of a protein called prostate specific antigen (PSA). But it is controversial and the UK's National Screening Committee does not recommend it. PSA tests are used to guide doctors and help monitor tumours. But using them to screen healthy people means they miss some cancers and cannot distinguish between people with high PSA levels who need treatment and those who do not. Read full story Source: BBC News, 27 December 2021
  11. News Article
    A trial testing for Group B Strep during pregnancies has been welcomed by a mum who lost her son to the bacterial infection. The trial at Derriford Hospital will see routine testing for the bacteria that can put newborns at risk. Dawn Byly lost her third child Leo to the infection a day after he was born in Truro in 2003. "I would love to think this might help prevent other families going through such a traumatic loss," she said. About one in four pregnant women are carriers of Group B Strep. Most do not have any symptoms, but it can spread to their child during labour and in a small number of cases the infection can be life-threatening. Currently only women identified as being at risk are tested and if positive are offered antibiotics during labour and birth. Tests are available privately and involve a late swab in pregnancy. "Suffering the loss of a child is a tragedy and we are committed to making sure all women get the right support and best possible maternity care," said the Department of Health and Social Care. "The UK National Screening Committee reviewed the evidence to screen for Group B Strep at 35 to 37 weeks of pregnancy in 2017 and concluded there was insufficient evidence to introduce a national screening programme," it added. Dr Alexander Taylor, from Derriford Hospital in Plymouth, said: "It's felt uncomfortable as an obstetrician in the UK knowing America, Canada and many of our European neighbours have been routinely screening for Group B Strep. "This large trial aims to uncover both the clinical effectiveness but also the cost effectiveness of instituting a programme like this." Read full story Source: BBC News, 9 November 2021
  12. News Article
    About a third of NHS trusts in England are using “technically obsolete” imaging equipment that could be putting patients’ health at risk, while existing shortages of doctors who are qualified to diagnose and treat disease and injuries using medical imaging techniques could triple by 2030. According to data obtained through freedom of information requests by Channel 4’s Dispatches programme, 27.1% of trusts in NHS England have at least one computerised tomography (CT) scanner that is 10 years old or more, while 34.5% have at least one magnetic resonance imaging (MRI) scanner in the same category. These are used to diagnose various conditions including cancer, stroke and heart disease, detect damage to bones and internal organs, or guide further treatment. An NHS England report published last year recommended that all imaging equipment aged 10 years or older be replaced. Software upgrades may not be possible on older equipment, limiting its use, while older CT scanners may require higher radiation doses to deliver the same image, it said. Dr Julian Elford, a consultant radiologist and medical director at the Royal College of Radiologists (RCR), said: “CT and MRI machines start to become technically obsolete at 10 years. Older kit breaks down frequently, is slower, and produces poorer quality images, so upgrading is critical." “We don’t just need upgraded scanners, though; we need significantly more scanners in the first place. The [NHS England report] called for doubling the number of scanners – we firmly support that call, and recommend a government-funded programme for equipment replacement on an appropriate cycle so that radiologists can diagnose and treat their patients safely." Read full story Source: The Guardian, 18 October 2021
  13. News Article
    Cancer screening programmes designed to save hundreds of lives have been delayed by up to a year as services struggle with staff and equipment shortages, HSJ can reveal. Of the 14 Lung Health Check Programme sites announced last year, four — or just under a third — have either halted programmes they had started or delayed beginning them, with some now expected not to be operational until after March. The areas chosen for the scheme activities, which often involved mobile computed tomography units in vans, have high rates of late diagnosis lung cancer. A study published in the New England Journal of Medicine in February showed CT scanning of high risk groups led to a 26% reduction in deaths in men and between a 39 and 61% reduction in women. NHS England confirmed “activity had resumed” in nine areas while one has started this month, meaning four areas remain out of action. The organisation declined to answer HSJ’s questions on which services were not running and why. Read full story (paywalled) Source: HSJ, 1 December 2020
  14. News Article
    People awaiting a CT or MRI scan will be able to have one on the high street under NHS plans to improve access to diagnostic tests. NHS England plans to set up a network of new “one-stop shops” where patients will be able to have scans closer to home rather than having to go hospital. They are intended to reduce the risk of patients getting COVID-19 in hospital and speed up the time it takes to undergo diagnostic testing by having more capacity. NHS England’s governing board approved a plan on Thursday by Prof Sir Mike Richards to create “community diagnostic hubs across the country over the next few years”. It is part of a planned “radical overhaul” in the way patients access a range of diagnostic tests, screening appointments and other services. The hubs, which would open six days a week, may also perform blood tests, lung function checks and endoscopies, in which a camera is put down the throat. The new facilities would be sited in disused shops or in shopping centres. They are part of the NHS’s drive to make it easier for people to be tested without having to go to hospital, amid concern that reluctance to do so is part of the reason fewer people are undergoing cancer screening. It is already undertaking lung cancer tests in 10 mobile centres that are parked at supermarkets and shopping centres. Bigger hubs could also offer mammograms, eye health checks, scans for pregnant women, hearing tests and gynaecological services. Hospital bosses welcomed the plan, which they said should reduce waiting times. Miriam Deakin, the director of policy and strategy at NHS Providers, which represents NHS trusts, said: “Doing these checks in the community rather than in hospital could support trusts as they grapple with a second wave of Covid-19, winter pressures and tackling backlogs of care.” Read full story Source: The Guardian, 1 October 2020
  15. News Article
    Almost one million women in the UK have missed vital breast screening due to coronavirus, a leading charity has estimated. Breast screening programmes were paused in March as the NHS focused resources on tackling the pandemic. Breast Cancer Now calculates that around 8,600 women who have not had a scan have undetected breast cancer. The scanning programme is running again, but social distancing measures have reduced capacity. Combined with the significant backlog of women waiting for a scan, and more women starting to come forward with concerns about possible symptoms, the charity warns the service is under intense pressure. Breast cancer diagnosed at a later stage can be harder to treat. Breast Cancer Now estimates that a total of 986,000 women across the UK missed their mammograms due to breast screening programmes being paused. The estimate is based on the average number of women screened per month, and the approximate length of time the screening programme was suspended, in each part of the UK. This breaks down to almost 838,000 women in England, 78,000 in Scotland, 48,000 in Wales and 23,000 in Northern Ireland. The charity is calling for an action plan and new resources to tackle the problem. Baroness Delyth Morgan, Breast Cancer Now chief executive, said: "That nearly one million women across the UK were caught up in the backlog waiting for breast screening is cause for grave concern. "Mammograms are a key tool in the early detection of breast cancer, which is critical to stopping women dying from the disease. "We understand that the breast screening programme was paused out of necessity due to the global Covid-19 pandemic, but we must now press play to ensure that all women can access breast screening, and we cannot afford for the programme to be paused again." Read full story Source: BBC News, 30 September 2020 Breast Cancer Now press release
  16. News Article
    The number of patients with cancer referred from screening services has fallen to nearly a third of pre-covid levels, new data shows. A total of 2,604 patients had their cancer picked up by screening services between April to July. This compares to 7,204 in the same period last year. The NHS England data covers patients receiving treatment within two months of a referral from screening services. This means the April 2020 data is largely from screening carried out before cOVID-19 saw services being shut down. From May to July this year, 1,243 patients were treated after a referral from screening services, compared to 5,406 in the same period last time. NHS England which commissions screening services from trusts said no central decision had been taken to halt screening at the height of the outbreak but said: “We know that some local providers did take the decision to pause and in those cases plans are in place to get services fully up and running again.” The national screening programmes look for bowel, breast and cervical cancers. Head of policy at Macmillan Cancer Support Sara Bainbridge said: ”Behind every missed target is a real person whose prognosis and treatment options could be severely impacted by these delays. It’s vital that people see their GP if they have symptoms, and anyone who is worried about cancer needs to know that they’ll be seen promptly and safely." “Cancer must not become the forgotten ‘C’ during this pandemic – we urgently need the government to deliver the promised recovery plan and make sure the NHS has all the staffing and resources it needs to get cancer services back on track.” Read full story (paywalled) Source: HSJ, 10 September 2020
  17. News Article
    Hundreds of women with breast cancer in London were not picked up by routine screening as services closed during the lockdown, officials have estimated. Data from NHS England and Improvement’s London office said it expected 450 people to have breast cancer and have gone undiagnosed because of the heavily reduced amount of screening at the height of the outbreak. It was included in a letter from officials to local health system leaders, seen by HSJ. It said the figure was an estimate based on the 115,000 routine breast screenings that would have taken place between late March and the end of June and which had to be re-scheduled. London represents around 15% of England’s population, so a nationwide estimate would run into thousands. Responding to the figures, Breast Cancer Now chief executive Baroness Delyth Morgan said: ”While it’s encouraging that the breast screening programme in London is now back up and running, we are concerned to hear of the hundreds of potential delayed cancer diagnoses as a result of disruption due to the pandemic. The earlier breast cancer is diagnosed, the more likely treatment is to be successful." “With over a hundred thousand people missing out on vital breast screening during the pandemic in London alone, we urge the government to ensure there is sufficient capacity in the already-stretched workforce to meet the huge backlog and to avoid any cancers going undetected for longer.” Read full story (paywalled) Source: HSJ, 9 September 2020
  18. News Article
    Many dread being invited for their cervical smear test - but Laurie Hodierne found it exhausting to have to keep asking for appointments, and trying to chase up the result. He is one of a number of transgender men who still have a cervix but are no longer registered as female at their GP surgery. Laurie was re-registered as male without requesting it, he says. And this means he could miss out on potentially life-saving cervical smear tests because he is not automatically called up for screenings. As a doctor, Laurie worries others who might be less able to navigate the health system will simply give up trying to get their smear test. "I understand how the systems work and the language - and despite all of that I find it exhausting," he says. "You keep coming up against a brick wall. It's a healthcare inequality in the sense that you aren't able to get access to the screening programme in the same way." NHS patients registered as female are invited to a cervical-cancer screening every three years between the ages of 25 and 50, and then every five years until they are 65. But anyone who has a cervix can develop cervical cancer. The disease often has no symptoms in its early stages and can be fatal. Read full story Source: BBC News, 17 May 2021
  19. News Article
    Patients awaiting a diagnostic test are to be assessed according to risk of becoming disabled as the service tries to prioritise in the face of huge backlogs. NHS England guidance released yesterday said local teams should categorise diagnostic waits on a four-point scale so those in most urgent need are seen first. It said this would mean, “recognising that for less urgent or routine diagnostics, some patients may experience a delay”. The diagnostics data for February showed 1.15 million people waiting for a test, compared to 1.08m in February 2020 – however, the proportion of people waiting more than 13 weeks rose from 0.6% in 2020 to 28.5% this year. The number of people on the list waiting more than six weeks also increased five-fold over the year. No more than 1% of patients are supposed to wait longer than six weeks for a diagnostic test, under government waiting time standards. The NHS England guidance puts diagnostics on the same footing as elective treatment, which has been organised according to clinical priority – P1 being the most urgent P4 being the least — since shortly after the pandemic hit last year. Read full story (paywalled) Source: HSJ, 13 May 2021
  20. News Article
    Patients with life-threatening coronary heart disease will be treated five times faster thanks to 3D scans being introduced on the NHS that allow for a diagnosis in just 20 minutes. The revolutionary technology can turn a regular CT scan of the heart into a 3D image, allowing doctors to diagnose them rapidly, NHS England said. It added that about 100,000 people will be eligible to use the HeartFlow technology over the next three years. Patients – who would previously have had to undergo an invasive and time-consuming angiogram in hospital – will now be seen, diagnosed and treated around five times faster. The new technology, introduced from last month, is part of the NHS long-term plan to cut the number of heart attacks and strokes by 150,000. NHS England said more people here will have access to the potentially life-saving technology than anywhere else in Europe, the US or Japan. Matt Whitty, director of innovation and life sciences for NHS England, said HeartFlow had been a “huge success” in clinical trials and would now help “tens of thousands of people a year receive quick diagnosis and treatment and ultimately save lives”. Read full story Source: The Guardian. 4 May 2021
  21. News Article
    A man who died from lung cancer might have been saved if a hospital trust had not "failed to act" on two abnormal chest X-rays, an investigation found. Growths identified in the patient's examinations were not followed up for three years and were then untreatable, the health ombudsman said. North Cumbria University Hospitals NHS Trust also failed to correctly handle a complaint from the man's daughter. The trust, which runs hospitals in Carlisle and Whitehaven, apologised. The investigation was carried out by the Parliamentary and Health Service Ombudsman (PHSO), which deals with unresolved NHS England complaints. The patient, referred to only as Mr C, was admitted twice to hospital with stroke-like symptoms in 2014 and 2015. On both occasions X-rays were carried out which found abnormal growths in his lungs, but no action was taken. In July 2017, Mr C was found to have advanced lung cancer and he died weeks later. Read full story Source: BBC News, 29 April 2021
  22. News Article
    Nearly 30 patients suffered severe or moderate harm due to quality issues with ultrasounds carried out by an independent provider, a review has found. Scans of 1,800 patients carried out by two sonographers employed by Bestcare Diagnostics were examined as part of a clinical harm review initiated by Coastal West Sussex Clinical Commissioning Group in 2019. Papers for next week’s governing body meeting of West Sussex CCG — which has absorbed Coastal West Sussex CCG — reveal the review found 29 cases of severe or moderate harm. According to the NHS’ National Recording and Learning System, moderate harm is that where a patient needs further treatment or procedures but the harm is short-term. Severe harm results in permanent or long-term harm. Both require NHS bodies to exercise the duty of candour. Read full story (paywalled) Source: HSJ, 6 April 2021
  23. News Article
    NHS Supply Chain has suspended supplies of some ultrasound gels over concerns they might be connected with outbreaks of bacterial infections in multiple hospitals. Thirty hospitals have reported 46 cases of Burkholderia contaminans between October last year and January 2021. No patients have died but some developed sepsis symptoms. NHS Supply Chain has suspended supplies of three ultrasound gels as a “precautionary measure” and guidance has been updated on the safe use of gel to reduce the risk of transmission of infection. Existing stocks have not been recalled and NHS Supply Chain is stocking similar products as alternatives. Public Health England has said its provisional investigation suggests a potential link with ultrasound or ultrasound-guided procedures as many of the infected patients had undergone these before the bacterium was identified. It is also investigating how many of the patients have spent time in intensive care or high dependency settings. A related bacteria, called Burkholderia cepacian, was also found in 27 cases. Read full story (paywalled) Source: HSJ, 4 March 2021
  24. News Article
    A review of the work of a former locum consultant radiologist in the Northern Trust has identified major discrepancies in 66 images. The trust has concluded a review of 13,030 scans and x-rays. The review was launched in June after the General Medical Council raised concerns about the locum consultant radiologist's work. The highest level of hospital investigation will be carried out into the cases of 17 patients. More than 9,000 patients were contacted as part of the review. The review identified six images at level one - a major discrepancy where errors or omissions in reporting could have had an immediate and significant clinical impact for the patients concerned. A further 60 images were level two - a major discrepancy with a probable clinical impact. "Most of the images categorised as having Level 1 and Level 2 discrepancies are CT scans but some are MRI scans, chest x-rays and other x-rays," said the trust's medical director, Seamus O'Reilly. "That detailed clinical assessment, which has resulted in 69 patients being called back, was to determine whether any clinical harm occurred as a result of the discrepancies found in the lookback review," "I can confirm that following careful consideration, the clinical assessment group has determined that 17 patients should now be part of a Level 3 Serious Adverse Incident (SAI) review." Read full story Source: BBC News, 13 October 2021
  25. News Article
    The number of women in the UK who have not had vital NHS breast screening, which can stop people dying from breast cancer, has risen by an estimated 50% - to nearly 1.5 million women - since services resumed, the leading UK breast cancer charity warns during Breast Cancer Awareness Month. Breast Cancer Now reveals an alarming increase of around half a million women who haven’t been screened since services restarted in summer 2020, estimating that around 1,480,000 fewer women in the UK had breast screening between March 2020 and May 2021, compared to pre-pandemic levels. This comes a year after the charity reported that almost one million women had missed breast screening due to COVID-19 seeing services paused. According to the charity, nearly 12,000 people in the UK could have been living with undiagnosed breast cancer at the end of May 2021, due to the impact of the pandemic on breast screening services and fewer women being referred to specialists with possible symptoms of the disease since March 2020 – a frightening prospect when early detection can stop people dying from the disease. Full article here Source: Breast Cancer Now Also covered in the Independent
×
×
  • Create New...